A descriptive study of uterine sarcomas.
A descriptive study of 67 patients with uterine sarcoma reveals the patients to be elderly (mean age 73 years) with significant co-existent medical problems. Despite this, primary surgical therapy is associated with minimal morbidity. Overall, survival is 63% for disease confined to the uterine corpus, and considerably less for more extensive disease. Nodal status, depth of myometrial invasion, peritoneal washings, cervical involvement, histologic type of sarcoma and treatment do not accurately predict survival. Patients alive 26 months after treatment are likely to survive their disease.